{
  "trial_id": "NCT00567554",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Written informed consent",
      "label": "met"
    },
    {
      "criterion": "Complete baseline documentation sent to GBG Forschungs GmbH;",
      "label": "met"
    },
    {
      "criterion": "Tumor lesion in the breast with a palpable size of \u2265 2 cm or a sonographically size of at least 1 cm in maximum diameter.",
      "label": "met"
    },
    {
      "criterion": "Patients should have stages of disease in which adjuvant chemotherapy would be considered.",
      "label": "met"
    },
    {
      "criterion": "Locally advanced tumors with cT4 or cT3",
      "label": "met"
    },
    {
      "criterion": "Age older than 18 years;",
      "label": "met"
    },
    {
      "criterion": "Karnofsky Performance status index at least 80%;",
      "label": "met"
    },
    {
      "criterion": "Normal cardiac function must be confirmed by ECG and cardiac ultrasound (LVEF or shortening fraction) within 1 month prior to registration.",
      "label": "unknown"
    },
    {
      "criterion": "Hematology: Absolute neutrophil count (ANC) \u2265 2.0 x 10e9/L platelets \u2265 100 x 10e9/L, Hemoglobin \u2265 10 g/dL (\u2265 6.2 mmol/L)",
      "label": "met"
    },
    {
      "criterion": "Hepatic function: Total bilirubin < 1 x UNL ASAT (SGOT) and ALAT (SGPT)\u2264 2.5 x UNL",
      "label": "unknown"
    },
    {
      "criterion": "Renal function: Creatinine \u2264 175 \u00b5mol/L (2 mg/dL) < 1,25 UNL (or the calculated creatinine clearance \u2265 60 mL/min)",
      "label": "met"
    },
    {
      "criterion": "Paraffin tumor tissue block and two serum samples centrally made available",
      "label": "unknown"
    },
    {
      "criterion": "Negative pregnancy test (urine or serum)",
      "label": "met"
    },
    {
      "criterion": "Complete staging work-up within 3 months prior to registration.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with low or moderate risk, which are only doubtful candidates for adjuvant chemotherapy",
      "label": "triggers"
    },
    {
      "criterion": "Evidence of distant metastasis;",
      "label": "triggers"
    },
    {
      "criterion": "Prior chemotherapy for any malignancy;",
      "label": "triggers"
    },
    {
      "criterion": "Pregnant or lactating patients.",
      "label": "triggers"
    }
  ],
  "notes": "Patient is a 12 year old girl with Turner syndrome, treating with GH since 6 months ago. She has short stature, delayed in puberty and developmental delay.",
  "_meta": {
    "topic_id": "49",
    "trial_id": "NCT00567554",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}